Skip to main content
. 2020 May 25;61(6):471–481. doi: 10.3349/ymj.2020.61.6.471

Fig. 1. The expression of ACOT7 in GC. (A) Boxplot showing the relative expression of ACOT7 in normal and GC samples (*p<0.05). (B) Kaplan-Meier curves of overall survival in patients with high or low ACOT7 expression in TCGA-GC. (C) The relative expression of ACOT7 in GC tissues by qRT-PCR assay. **Compared with the para-carcinoma tissues group, p<0.01, ***Compared with the para-carcinoma tissues group, p<0.001. (D) Western blot analysis of the expression of ACOT7 in GC tissues. ***Compared with para-carcinoma tissues group, p<0.001. (E) Western blot analysis of the expression of ACOT7 protein in the normal human gastric epithelial cell line GES-1 and a panel of GC cell lines. (F) The relative expression of ACOT7 mRNA normalized to GAPDH in GES-1 cells and a panel of GC cell lines. *Compared with GES-1 cells, p<0.05, ***Compared with para-carcinoma tissues group, p<0.001. STAD: stomach adenocarcinoma; ACOT7, acyl-CoA thioesterase 7; GC, gastric cancer; TCGA, The Cancer Genome Atlas.

Fig. 1